MedPath

WEight Loss in Learning Disabilities and Obesity (WELLDO): A weight loss intervention for adults with learning disabilities and obesity

Not Applicable
Completed
Conditions
Obesity
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN52903778
Lead Sponsor
HS Greater Glasgow and Clyde (UK)
Brief Summary

2015 protocol in https://pubmed.ncbi.nlm.nih.gov/27965785/

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
66
Inclusion Criteria

1. A learning disability
2. Over 18 years old (there is no upper age limit)
3. Body mass index (BMI) greater than or equal to 30 kg/m2
4. Able to walk independently
5. Not currently on a prescribed or restricted diet e.g. for phenylketonuria or diabetes
6. No intentional weight loss over the previous 3 months

Exclusion Criteria

1. Individuals with genetic syndromes, Prader Willi syndrome, Cohen syndrome or Bardet- Biedl syndrome (need a specific program to support weight loss)
2. Currently taking part in another research study
3. Pregnant
4. Taking medication prescribed for the purpose of weight loss or over the counter medication designed for weight loss

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body weight is measured using data collected at baseline, 6 months post randomisation and 12 months post randomisation
Secondary Outcome Measures
NameTimeMethod
<br> 1. Weight loss of 5% or more of initial body weight (Yes/No)<br> 2. Change in BMI<br> 3. Change in waist circumference<br> 4. Change in percentage body fat<br> 5. Mean percentage time per day spent engaged in moderate/vigorous intensity physical activity, measured by accelerometers<br> 6. Mean percentage time per day spent engaged in light intensity physical activity, measured by accelerometers<br> 7. Mean percentage time per day spent engaged in sedentary behaviour, measured by accelerometers<br> 8. Quality of life as measured by the EQ-5D<br><br> Data will be collected at baseline, 6 months post randomisation and 12 months post randomisation.<br>
© Copyright 2025. All Rights Reserved by MedPath